pharma jobs news from FiercePharma
News
Sanofi to cut 817 French reps
Sanofi-Aventis' French sales reps aren't happy right now. The company is following through on its previously... Read more...
GlaxoSmithKline to axe 850 jobs in R&D
Moving forward with its restructuring plan, GlaxoSmithKline announced to employees via email today that it would be laying off as many as 850 (6%) employees in its research and development units in... Read more...
Caraco to add 600 jobs by 2012
Even in this era of big pharma layoffs, a few companies are still adding jobs. Take generics maker Caraco Pharmaceutical Laboratories, majority-owned by of India's Sun Pharmaceuticals. The company is... Read more...
Pfizer layoff talk boosts stock
While the financial markets teeter, Pfizer stock closed 4 percent higher yesterday as rumors of more layoffs swirled. Never mind that Read more...
Senior staff: what attracts them and why they stay
By Jodi Andrews We all know that one of the most valuable resources in the clinical research industry is staff. Recruiting and training budgets are high, and we depend on knowledgeable staff to... Read more...
Chemists laid off at GlaxoSmithKline
GlaxoSmithKline's June announcement that it was cutting 350 jobs worldwide is coming to fruition. The company just laid off... Read more...
IMS: Pace of outsourcing accelerating
Drugmakers are pulling out of manufacturing at an unprecedented rate, according to a new report from IMS Health. Four of the top... Read more...
FDA aims to hire 1,300 by October
In answer to its critics, FDA is mounting a major hiring push to expand its drug safety operations. By October, it hopes to add 1,300 to its payroll--600 new positions and 700 vacancies that have... Read more...
Pfizer got tax break but didn't deliver jobs
As Pfizer held its big conference call with analysts this morning, the New York Daily News was reporting on the company's job cuts and plant closure in Manhattan and Brooklyn. At issue: a $10... Read more...
Ex-Malaysia PM blames Pharma for brain drain
A former prime minister of Malaysia is hopping mad at Western companies that poach top talent from his country. Mahathir Mohamad's prime target: Big Pharma, which he says steals the best researchers... Read more...
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
